{"2410.19412": {"publish_time": "2024-10-25", "title": "Robust Time Series Causal Discovery for Agent-Based Model Validation", "paper_summary": "Agent-Based Model (ABM) validation is crucial as it helps ensuring the\nreliability of simulations, and causal discovery has become a powerful tool in\nthis context. However, current causal discovery methods often face accuracy and\nrobustness challenges when applied to complex and noisy time series data, which\nis typical in ABM scenarios. This study addresses these issues by proposing a\nRobust Cross-Validation (RCV) approach to enhance causal structure learning for\nABM validation. We develop RCV-VarLiNGAM and RCV-PCMCI, novel extensions of two\nprominent causal discovery algorithms. These aim to reduce the impact of noise\nbetter and give more reliable causal relation results, even with\nhigh-dimensional, time-dependent data. The proposed approach is then integrated\ninto an enhanced ABM validation framework, which is designed to handle diverse\ndata and model structures.\n  The approach is evaluated using synthetic datasets and a complex simulated\nfMRI dataset. The results demonstrate greater reliability in causal structure\nidentification. The study examines how various characteristics of datasets\naffect the performance of established causal discovery methods. These\ncharacteristics include linearity, noise distribution, stationarity, and causal\nstructure density. This analysis is then extended to the RCV method to see how\nit compares in these different situations. This examination helps confirm\nwhether the results are consistent with existing literature and also reveals\nthe strengths and weaknesses of the novel approaches.\n  By tackling key methodological challenges, the study aims to enhance ABM\nvalidation with a more resilient valuation framework presented. These\nimprovements increase the reliability of model-driven decision making processes\nin complex systems analysis.", "paper_summary_zh": "\u57fa\u65bc\u4ee3\u7406\u7684\u6a21\u578b (ABM) \u9a57\u8b49\u81f3\u95dc\u91cd\u8981\uff0c\u56e0\u70ba\u5b83\u6709\u52a9\u65bc\u78ba\u4fdd\u6a21\u64ec\u7684\u53ef\u9760\u6027\uff0c\u800c\u56e0\u679c\u767c\u73fe\u5df2\u6210\u70ba\u5728\u6b64\u8108\u7d61\u4e2d\u5f37\u5927\u7684\u5de5\u5177\u3002\u7136\u800c\uff0c\u7576\u61c9\u7528\u65bc\u8907\u96dc\u4e14\u6709\u96dc\u8a0a\u7684\u6642\u9593\u5e8f\u5217\u8cc7\u6599\u6642\uff0c\u7576\u524d\u7684\u56e0\u679c\u767c\u73fe\u65b9\u6cd5\u901a\u5e38\u6703\u9762\u81e8\u6e96\u78ba\u5ea6\u548c\u7a69\u5065\u6027\u7684\u6311\u6230\uff0c\u9019\u5728 ABM \u60c5\u5883\u4e2d\u5f88\u5e38\u898b\u3002\u672c\u7814\u7a76\u900f\u904e\u63d0\u51fa\u7a69\u5065\u4ea4\u53c9\u9a57\u8b49 (RCV) \u65b9\u6cd5\u4f86\u89e3\u6c7a\u9019\u4e9b\u554f\u984c\uff0c\u4ee5\u52a0\u5f37 ABM \u9a57\u8b49\u7684\u56e0\u679c\u7d50\u69cb\u5b78\u7fd2\u3002\u6211\u5011\u958b\u767c\u4e86 RCV-VarLiNGAM \u548c RCV-PCMCI\uff0c\u9019\u662f\u5169\u7a2e\u5091\u51fa\u7684\u56e0\u679c\u767c\u73fe\u6f14\u7b97\u6cd5\u7684\u65b0\u5ef6\u4f38\u3002\u5b83\u5011\u65e8\u5728\u66f4\u597d\u5730\u964d\u4f4e\u96dc\u8a0a\u7684\u5f71\u97ff\uff0c\u4e26\u63d0\u4f9b\u66f4\u53ef\u9760\u7684\u56e0\u679c\u95dc\u4fc2\u7d50\u679c\uff0c\u5373\u4f7f\u5728\u9ad8\u7dad\u5ea6\u3001\u6642\u9593\u76f8\u95dc\u7684\u8cc7\u6599\u4e2d\u4e5f\u662f\u5982\u6b64\u3002\u7136\u5f8c\u5c07\u6240\u63d0\u51fa\u7684\u65b9\u6cd5\u6574\u5408\u5230\u589e\u5f37\u7684 ABM \u9a57\u8b49\u67b6\u69cb\u4e2d\uff0c\u8a72\u67b6\u69cb\u65e8\u5728\u8655\u7406\u591a\u6a23\u5316\u7684\u8cc7\u6599\u548c\u6a21\u578b\u7d50\u69cb\u3002\n\u4f7f\u7528\u5408\u6210\u8cc7\u6599\u96c6\u548c\u8907\u96dc\u7684\u6a21\u64ec fMRI \u8cc7\u6599\u96c6\u4f86\u8a55\u4f30\u8a72\u65b9\u6cd5\u3002\u7d50\u679c\u8b49\u660e\u56e0\u679c\u7d50\u69cb\u8b58\u5225\u7684\u53ef\u9760\u6027\u66f4\u9ad8\u3002\u672c\u7814\u7a76\u63a2\u8a0e\u4e86\u8cc7\u6599\u96c6\u7684\u5404\u7a2e\u7279\u5fb5\u5982\u4f55\u5f71\u97ff\u5df2\u5efa\u7acb\u7684\u56e0\u679c\u767c\u73fe\u65b9\u6cd5\u7684\u6548\u80fd\u3002\u9019\u4e9b\u7279\u5fb5\u5305\u62ec\u7dda\u6027\u3001\u96dc\u8a0a\u5206\u4f48\u3001\u5e73\u7a69\u6027\u548c\u56e0\u679c\u7d50\u69cb\u5bc6\u5ea6\u3002\u7136\u5f8c\u5c07\u6b64\u5206\u6790\u5ef6\u4f38\u5230 RCV \u65b9\u6cd5\uff0c\u4ee5\u4e86\u89e3\u5b83\u5728\u9019\u4e9b\u4e0d\u540c\u60c5\u6cc1\u4e0b\u7684\u6bd4\u8f03\u60c5\u6cc1\u3002\u6b64\u6aa2\u67e5\u6709\u52a9\u65bc\u78ba\u8a8d\u7d50\u679c\u662f\u5426\u8207\u73fe\u6709\u6587\u737b\u4e00\u81f4\uff0c\u4e26\u63ed\u793a\u65b0\u65b9\u6cd5\u7684\u512a\u9ede\u548c\u7f3a\u9ede\u3002\n\u900f\u904e\u89e3\u6c7a\u95dc\u9375\u7684\u65b9\u6cd5\u8ad6\u6311\u6230\uff0c\u672c\u7814\u7a76\u65e8\u5728\u900f\u904e\u63d0\u51fa\u7684\u66f4\u5177\u5fa9\u539f\u529b\u7684\u8a55\u4f30\u67b6\u69cb\u4f86\u589e\u5f37 ABM \u9a57\u8b49\u3002\u9019\u4e9b\u6539\u9032\u63d0\u9ad8\u4e86\u5728\u8907\u96dc\u7cfb\u7d71\u5206\u6790\u4e2d\u6a21\u578b\u9a45\u52d5\u6c7a\u7b56\u5236\u5b9a\u7a0b\u5f0f\u7684\u53ef\u9760\u6027\u3002", "author": "Gene Yu et.al.", "authors": "Gene Yu, Ce Guo, Wayne Luk", "id": "2410.19412v1", "paper_url": "http://arxiv.org/abs/2410.19412v1", "repo": "null"}}